Patent details

EP2101731 Title: ENDOXIFEN FOR USE IN THE TREATMENT OF CANCER

Basic Information

Publication number:
EP2101731
PCT Application Number:
US2007085443
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP078715638
PCT Publication Number:
WO2008070463
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ENDOXIFEN FOR USE IN THE TREATMENT OF CANCER
French Title of Invention:
ENDOXIFÈNE POUR UTILISATION DANS LE TRAITEMENT DU CANCER
German Title of Invention:
ENDOXIFEN FÜR DIE VERWENDUNG IN DER BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
21/11/2007
Grant date:
31/01/2018
EP Publication Date:
23/09/2009
PCT Publication Date:
12/06/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
31/01/2018
EP B1 Publication Date:
31/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/11/2018
Expiration date:
21/11/2027
Renunciation date:
Revocation date:
06/04/2023
Annulment date:

Owner

From:
24/01/2018
 
 

Name:
Jina Pharmaceuticals Inc.
Address:
28100 North Ashley Circle, Suite 103, Libertyville IL 60048, United States (US)

Inventor

1

Name:
SHEIKH, Saifuddin
Address:
United States (US)

2

Name:
AHMAD, Imran
Address:
United States (US)

3

Name:
AHMAD, Ateeq
Address:
United States (US)

4

Name:
ALI, Shoukath M.
Address:
United States (US)

5

Name:
AHMAD, Moghis U.
Address:
United States (US)

Priority

1

Priority Number:
860420 P
Priority Date:
21/11/2006
Priority Country:
United States (US)

2

Priority Number:
860788 P
Priority Date:
22/11/2006
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 9/127; A61K 9/19; A61K 31/138; A61K 31/35; A61P 35/00; C07D 309/10;

Publication

European Patent Bulletin

1

Issue number:
201805
Publication date:
31/01/2018
Description:
Grant (B1)

2

Issue number:
201849
Publication date:
05/12/2018
Description:
Opposition procedure started

3

Issue number:
202325
Publication date:
21/06/2023
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/03/2019 Outgoing Correspondence 1